Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors
WASHINGTON, Oct. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today announced the appointment of Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to the Danaher Board of Directors on October 9, 2026. Dr. Hershberg has also been appointed to the...
Covered in this story
What has happened since
- Danaher Corporation is up 0.7% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Danaher Corporation
- UBS: $205 → $250 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DHR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Danaher Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.